Search clinical trials for: Papillary Thyroid Carcinoma
Total 31789 results
-
Mayo ClinicNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedThyroid Cancer | Differentiated Thyroid Cancer | Anaplastic Thyroid CancerUnited States
-
Hoffmann-La RocheWithdrawn
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruiting
-
National Cancer Institute (NCI)CompletedUrinary Bladder NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedRefractory Malignant Solid Neoplasm | Recurrent Melanoma | Recurrent Malignant Solid Neoplasm | Recurrent Thyroid Gland Carcinoma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Thyroid Gland Medullary CarcinomaUnited States, Canada
-
European Organisation for Research and Treatment...PfizerCompletedLocally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma | Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor | Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 | Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma | Locally Advanced... and other conditionsFrance, Belgium, Netherlands, Germany, United Kingdom, Italy, Norway, Poland, Slovakia, Slovenia
-
M.D. Anderson Cancer CenterCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Unresectable Renal Cell... and other conditionsUnited States
-
Sun Yat-sen UniversityCompleted
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited States, Korea, Republic of, Taiwan, France, Hong Kong, Belgium, Spain
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdActive, not recruitingDifferentiated Thyroid CancerChina
-
University Medical Center GroningenDutch Cancer SocietyEnrolling by invitationSurgery | Thyroid CarcinomaNetherlands
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Kidney Medullary Carcinoma | Kidney Oncocytoma | Carcinoma of the Collecting Ducts of BelliniUnited States
-
Austral University, ArgentinaCompletedNodular Goiter | Medullary Thyroid CarcinomaArgentina
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Metastatic Melanoma | Thyroid Gland Carcinoma | Metastatic Malignant Neoplasm of Unknown Primary | Spinal Cord Compression | Stage IV Breast Cancer AJCC v6 and v7 | Malignant Digestive System Neoplasm | Metastatic Malignant Neoplasm in the Spine | Metastatic Kidney Carcinoma | Metastatic Head... and other conditionsUnited States
-
Genzyme, a Sanofi CompanyActive, not recruitingThyroid CancerUnited States, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark, France, Germany, Hungary, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, Serbia, Spain, Sweden, Switz...
-
Genzyme, a Sanofi CompanyActive, not recruitingTo Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerThyroid CancerUnited States, Italy, Poland, Russian Federation, United Kingdom, Netherlands, Israel, Czechia, India
-
Genzyme, a Sanofi CompanyActive, not recruitingMedullary Thyroid Cancer | Locally Advanced or Metastatic Medullary Thyroid CancerAustralia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Denmark, Finland, Germany, Greece, India, Israel, Italy, Korea, Republic of, Poland, Russian Federation, Sweden, United Kingdom
-
Sameek RoychowdhuryActive, not recruitingCholangiocarcinoma | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
RenJi HospitalActive, not recruitingInflammatory Breast Cancer | Invasive Ductal Breast Cancer | Tubular Breast Cancer | Mucinous Breast CancerChina
-
Shanghai Henlius BiotechActive, not recruitingAnaplastic Thyroid Cancer | ATCChina
-
Novartis PharmaceuticalsCompletedCancerFrance, Spain, Netherlands, Canada, Austria, United States, Germany, Italy, Japan, Norway, Korea, Republic of, Denmark, Sweden, Belgium
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
NCIC Clinical Trials GroupAriad PharmaceuticalsCompletedEndometrial CancerCanada
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruiting
-
GenmabCompletedMelanoma | Sarcoma | Cervical Cancer | Ovarian Cancer | Endometrial Cancer | Solid Tumors | Thyroid Cancer | Non Small Cell Lung Cancer (NSCLC)United States, United Kingdom, Belgium, Denmark, Netherlands, Spain
-
The Catholic University of KoreaCompletedHuerthle Cell Carcinoma
-
Rutgers, The State University of New JerseyUniversity of California, Los Angeles; University of New MexicoActive, not recruitingKidney Cancer | Small Intestine Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Colon Cancer | Thyroid Cancer | Rectum Cancer | Soft Tissue CancerUnited States
-
ExelixisActive, not recruitingRenal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Urothelial Carcinoma | Differentiated Thyroid Cancer | Gastroesophageal... and other conditionsUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Sesen Bio, Inc.CompletedBladder CancerUnited States, Canada
-
Eisai Pharmaceuticals India Pvt. LtdActive, not recruiting
-
ExelixisActive, not recruitingMedullary Thyroid CancerAustralia, France, Israel, Spain, Russian Federation, Netherlands, Hungary, Korea, Republic of, Croatia, Italy, Canada, Poland, Romania, Sweden
-
Lynkcell EuropeAvailableKidney Cancer | Clear Cell Kidney Cancer | Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
-
Eisai LimitedMerck Sharp & Dohme LLCCompletedOsteosarcoma | Tumors | Differentiated Thyroid Cancer (DTC) | Solid Malignant TumorsSpain, Italy, United States, United Kingdom, France, Germany
-
Memorial Sloan Kettering Cancer CenterNovartisActive, not recruitingAnaplastic Thyroid CancerUnited States
-
University Hospital, ToulouseActive, not recruitingPapillary CarcinomaFrance
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
Novo Nordisk A/SEli Lilly and Company; AstraZeneca; United BioSource, LLCEnrolling by invitationDiabetes Mellitus, Type 2 | Diabetes | Weight Management | Medullary Thyroid CarcinomaUnited States
-
BayerCompletedThyroid NeoplasmsUnited States, Japan, Turkey, Russian Federation, India, Germany, France, Mexico, Philippines, Greece, Netherlands, Spain, Taiwan, Brazil, Egypt, Argentina, Algeria, Lebanon, Saudi Arabia
-
Grupo Espanol de Tumores NeuroendocrinosRoche Pharma AG; IpsenActive, not recruitingAdenocarcinoma | Neuroendocrine Tumor | Pheochromocytoma | Paraganglioma | Anaplastic Thyroid CancerSpain
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingLow Risk Differentiated Thyroid CancerFrance
-
Jonsson Comprehensive Cancer CenterBeiGene; Driven To CureWithdrawnMetastatic Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Unresectable Renal Cell Carcinoma | Hereditary Leiomyomatosis and Renal Cell Carcinoma | Clear Cell Papillary Renal Neoplasm | Hereditary Papillary Renal Cell Carcinoma and other conditionsUnited States
-
Yale UniversityGenentech, Inc.CompletedEndometrial CancerUnited States
-
University of ChicagoActive, not recruitingLung Metastases | Liver Metastases | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | Invasive Lobular Breast Carcinoma | Central Nervous System Metastases | Tumors Metastatic to Brain | Lobular Breast Carcinoma in Situ | Invasive Ductal Breast Carcinoma | Medullary Ductal Breast Carcinoma... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Daiichi Sankyo, Inc.CompletedRecurrent Thyroid Cancer | Anaplastic Thyroid CancerUnited States
-
Grupo Español de Tratamiento de Tumores de Cabeza...Active, not recruitingDifferentiated Thyroid Carcinoma | Medullary Thyroid CarcinomaSpain
-
Yansong LinActive, not recruitingDTC - Differentiated Thyroid CancerChina
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedInflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Invasive Lobular Breast Carcinoma | Invasive Ductal Breast Carcinoma | Mucinous Ductal Breast Carcinoma | Papillary Ductal Breast Carcinoma | Tubular Ductal Breast CarcinomaUnited States